Valvular heart disease: medical therapy and experimental and animal models

Vasodilators have been advocated for the treatment of regurgitant valvular heart diseases for more than 12 years, and new information on their mechanisms of action is available. Anticoagulants continue as a mainstay of therapy for patients with prosthetic heart valves, and the most desirable levels...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current opinion in cardiology 1993-03, Vol.8 (2), p.222-228
Hauptverfasser:	Johns, Joseph P, Bryg, Robert J
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Anticoagulants - therapeutic use Catheterization - adverse effects Catheterization - methods Echocardiography Health technology assessment Heart Valve Diseases - drug therapy Heart Valve Diseases - surgery Heart Valve Diseases - therapy Heart Valve Prosthesis Humans Vasodilator Agents - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Vasodilators have been advocated for the treatment of regurgitant valvular heart diseases for more than 12 years, and new information on their mechanisms of action is available. Anticoagulants continue as a mainstay of therapy for patients with prosthetic heart valves, and the most desirable levels of anticoagulation for different conditions have been examined. Clinical and animal research studies of cardiac adaptation to mitral and aortic valve diseases are discussed.
ISSN:	0268-4705 1531-7080
DOI:	10.1097/00001573-199303000-00006